New stroke-prevention drug may not be cost effective for all patients
A new study has shown a stroke-prevention drug designed to be an improvement over prior treatments is less cost-effective for most patients than warfarin, the blood thinner with a 50-year history of helping prevent blood clots and strokes. The study, conducted by researchers at the School of Medicine found, however, that the new drug would be cost-effective for those atrial fibrillation patients whose risk of bleeding is high.
Alcoholism and accompanying disorders explored at Guze Symposium
Research on alcoholism and disorders that tend to occur with it will be presented by national experts at the fifth annual Guze Symposium on Alcoholism. The symposium is dedicated to the late Samuel B. Guze, M.D., a pioneer in alcoholism research, who served 18 years as vice chancellor for medical affairs and president of the Washington University Medical Center.
Jost named Chairman of the Radiological Society of North America
JostR. Gilbert Jost, M.D., the Elizabeth Mallinckrodt Professor and head of Radiology at the School of Medicine, has been named chairman of the board of directors of the Radiological Society of North America (RSNA). The society is an organization of more than 37,000 radiologists, radiation oncologists and related scientists.
February 2005 Radio Service
Listed below are this month’s featured news stories.
• Is field turf safe? (week of Feb. 2)
• Heart surgery and depression (week of Feb. 9)
• Reversing Alzheimer’s in mice (week of Feb. 16)
• Age affects cervical cancer treatments (week of Feb. 23)
Carefree people more apt to ignore cancer symptoms
Researchers report that people with low overall anxiety levels were more apt to ignore symptoms of rectal cancer for long periods of time.
Mice reveal possible source of depression
Genetic variations in a specific protein may be a significant cause of human depression, University researchers say.
Higher fluoride levels are found in instant tea
The researchers found some regular-strength preparations contain as much as 6.5 parts per million of fluoride, well over the 4 ppm maximum allowed.
Biotech boost
Photo by Robert BostonUniversity and city officials celebrate the groundbreaking of the nonprofit Center of Research, Technology & Entrepreneurial Exchange.
Brain cells recover after Alzheimer’s plaques removed
“This provides confirmation of the potential benefits of plaque-clearing treatments and also gets us rethinking our theories,” says senior author David H. Holtzman.
More medical news
Treating the whole patient
Sometimes, the innocence of youth is captured in a moment; other times, in a place. For Abby S. Hollander, M.D., associate professor of pediatrics, that place was — and is — summer camp. While growing up, Hollander spent many summers as a camper and counselor at Camp New Moon, tucked among pine trees in the […]
View More Stories